VT News

Calijah Kancey

Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 2025 results, driven by robust HIV drug sales, and raises full-year guidance, making its stock a top performer.
  • US and Israel warn of heightened terror threats to Jewish and Israeli communities in the UAE amid regional tensions.
  • Fortescue secures landmark $2B yuan loan in China, deepening ties and advancing green agenda.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 2025 results, driven by robust HIV drug sales, and raises full-year guidance, making its stock a top performer.
  • US and Israel warn of heightened terror threats to Jewish and Israeli communities in the UAE amid regional tensions.
  • Fortescue secures landmark $2B yuan loan in China, deepening ties and advancing green agenda.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Calijah Kancey

Top Topics

Trending in U.S.

World

Sport